The specialty market continues to thrive as therapeutic areas such as oncology and hematology represent the fastest growing product types in the bio/pharmaceutical market.  However, specialty products also bring with them unique challenges and opportunities compared to mass market products because of the unique and complex nature of the products.  This makes strategic planning to ensure access, use and reimbursement of the utmost importance.  One large component to product uptake and success is the determination of the optimal make up of your distribution and dispensing channels. Specialty wholesale distributors, specialty pharmacies, group purchasing agreements and direct distribution plans all offer a variety of benefits.  These groups can serve as barriers or partners to ensure access, use and reimbursement of your product.

The purpose of this conference is to address key considerations to ensure product is in the hands of the most likely forces that will ensure pull through and therefore lock in sizable usage.

Some of the topics to be covered include:

• Trends in the specialty market and distribution arrangements
• The impact of healthcare reform on the biologics reimbursement market
• Evaluation of how differing economic incentives by site of service influence distribution strategy
• Collecting, completing, integrating and using data garnered through non-retail distribution

• Leveraging buying groups within your launch strategy

Sponsors/Exhibitors:

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.